Maze Therapeutics, Inc. Common Stock (MAZE)
Healthcare
Biotechnology
—
26.90 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Maze Therapeutics, Inc. Common Stock (MAZE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -39 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -21 | -23 | 145 | -23 | -22 | -30 | -30 | -25 | -28 | -39 | -122 | |
| 1.0 | 1.0 | 1.0 | 0.9 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | 0.4 | 2.2 | |
| 2.1 | 2.6 | 2.3 | 2.1 | 2.3 | 2.9 | 3.2 | 3.2 | 3.9 | 6.1 | 7.1 | 20 | |
| 1.0 | -2.2 | 0.2 | 2.4 | -5.2 | 1.0 | -1.4 | -1.0 | 2.5 | -0.3 | -24 | -23 | |
| 0.0 | 0.0 | 0.3 | 0.2 | 0.1 | 0.6 | 0.3 | 0.4 | 0.1 | 0.0 | 0.1 | 0.6 | |
| 0.0 | 0.0 | -0.3 | -0.2 | -0.1 | -0.6 | -0.3 | -0.4 | -67 | -103 | 6.3 | -164 | |
| – | – | – | – | – | – | – | 0.6 | – | 0.6 | – | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 39 | 39 | |
| 0.0 | 16 | 25 | 0.2 | -2.2 | 70 | 127 | 0.6 | 144 | 3.6 | 42 | 190 | |
| -20 | -4.5 | 0.9 | 145 | -25 | 47 | 98 | -30 | 52 | -128 | 9.5 | -96 | |
| -20 | -21 | -24 | 145 | -23 | -23 | -30 | -30 | -25 | -28 | -39 | -122 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.